An audit of tumour marker utilization in Greece

European Journal of Internal Medicine

Volumn 20, Issue 3, 2009, Pages

  Ntaios, George ^a   Hatzitolios, Apostolos ^a   Chatzinikolaou, Anastasia ^a   Karalazou, Paraskevi ^a   Savopoulos, Christos ^a   Karamouzis, Michalis ^a   Pidonia, Ifigenia ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

AFP; CA 125; CA 15 3; CA19 9; CEA; Tumour markers

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; NEURON SPECIFIC ENOLASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; COST; FEMALE; GREECE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; ANTIGENS, NEOPLASM; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COST-BENEFIT ANALYSIS; FEMALE; GREECE; HEALTH CARE COSTS; HUMANS; KERATIN-19; MALE; MEDICAL AUDIT; MIDDLE AGED; MUCIN-1; NEOPLASMS; PHOSPHOPYRUVATE HYDRATASE; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 64749084506     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2008.07.026     Document Type: Article

References (18)

1. Duffy M. Role of tumour markers in patients with solid cancers: a critical review. Eur J Intern Med 18 (2007) 175-184
2. Ruoslahti E., Salaspuro M., Pihko H., Anderson L., and Seppala M. Serum a-fetoprotein: diagnostic significance in liver disease. Br Med J 8 (1974) 527-529
3. Thomas P., and Zamcheck N. Role of liver in clearance and excretion of circulating carcinoembriogenic antigen (CEA). Dig Dis Sci 28 (1983) 216-224
4. Steinberg W. The clinical utility of the CA 19-9 tumor associated antigen. Am J Gastroenterol 85 (1990) 350-35
5. Duffy M. PSA as a marker for prostate cancer. Ann Clin Biochem 33 (1996) 511-519
6. Basuyau J.P., Blanc-Vincent M.P., Bidart J.M., Daver A., Deneux L., Eche N., et al. Standards, options and recommendations (SOR) for tumor markers in breast cancer. SOR Working Group. Bull Cancer 87 (2000) 723-737
7. Duffy M.J., van Dalen A., Haglund C., Hansson L., Holinski-Feder E., Klapdor R., et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 43 (2007) 1348-1360
8. Locker G.Y., Hamilton S., Harris J., Jessup J.M., Kemeny N., Macdonald J.S., et al. ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer. J Clin Oncol 24 (2006) 5313-5327
9. In: Witliff J.L., and Kaplan L.A. (Eds). Guidelines for the analytical performance and clinical utility of tumor markers [Draft] (1998), NACB, Rye Brook, NY
10. Arioli D., Pipino M., Boldrini E., Amateis E., Cristani A., Ventura P., et al. Tumour markers in internal medicine: a low-cost test or an unnecessary expense? A retrospective study based on appropriateness. Intern Emerg Med 2 (2007) 88-94
11. Yilmaz G., Yilmaz F.M., Senes M., and Yucel D. Tumour markers requests in a general teaching Turkish hospital. Indian J Clin Biochem 22 (2007) 52-56
12. McDonnell M. An audit of tumor marker requests in Northern Ireland. Ann Clin Biochem 41 (2004) 378-384
13. Loi S., Haydon A.M., Shapiro J., Schwarz M.A., and Schneider H.G. Towards evidence-based use of serum tumour marker requests: an audit of use in a tertiary hospital. Intern Med J 34 (2004) 545-550
14. Calderon-Margalit R., Mor-Yosef S., Mayer M., Adler B., and Shapira S.C. An administrative intervention to improve the utilization of laboratory tests within a university hospital. Int J Qual Health Care 17 (2005) 243-248
15. Dekay M.L. Asch DA. Is the defensive use of diagnostic tests good for patients, or bad?. Med Decis Mak 18 (1998) 19-28
16. Solomon D.H., Hashimoto H., Daltroy L., and Liang M.H. Techniques to improve physicians' use of diagnostic tests: a new conceptual framework. JAMA 280 (1998) 2020-2027
17. Epstein A.M., and McNeil B.J. Physician characteristics and organizational factors influencing use of ambulatory tests. Med Decis Mak 5 (1985) 401-415
18. Greco P.J., and Eisenberg J.M. Changing physicians' practices. N Engl J Med 329 (1993) 1271-1273